Related Experiment Video

Updated: Oct 1, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity

Chun Jing1, Manal Abd El-Ghany, Carol Beesley

  • 1Department of Pathology, Faculty of Medicine, University of Liverpool, UK.

Journal of the National Cancer Institute
|April 4, 2002
PubMed
Abstract

Insights

The tazarotene-induced gene 1 (TIG1) may suppress prostate cancer growth. Decreased TIG1 expression is linked to increased metastasis, suggesting its potential as a therapeutic target for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer is a prevalent yet poorly understood malignancy.
  • Identifying genetic factors in prostate cancer metastasis is crucial for effective treatment.
  • This study investigates genes potentially involved in prostate cancer progression.

Purpose of the Study:

  • To identify genes with decreased expression in prostate cancer.
  • To investigate the role of tazarotene-induced gene 1 (TIG1) in prostate cancer.
  • To assess TIG1's impact on prostate cancer cell invasiveness and tumor growth.

Main Methods:

  • Selective subtractive differential gene display and PCR were used to identify candidate genes.
  • Tazarotene-induced gene 1 (TIG1) was selected for further analysis.
  • In vitro and in vivo assays assessed the functional impact of TIG1 expression.

Main Results:

  • TIG1 mRNA was found in normal prostate tissues but significantly reduced in malignant tissues.
  • Transfection of PC-3M cells with TIG1 reduced in vitro invasiveness by 11%.
  • TIG1 transfection decreased in vivo tumor weight in mice by 0.76 g.

Conclusions:

  • Tazarotene-induced gene 1 (TIG1) functions as a potential tumor suppressor gene.
  • Diminished TIG1 expression correlates with prostate cancer's malignant progression.
  • TIG1 represents a potential therapeutic target for prostate cancer intervention.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...